Shaw Xiaoyang Wu is a Clinical Biomarker Director at Vertex Pharmaceuticals, with prior experience as a Director at Amicus Therapeutics. Shaw obtained a Doctor of Philosophy (Ph.D.) in Pharmacology from UMass Chan Medical School between 1996 and 2001 and holds a Bachelor's degree in Biochemistry from Nanjing University.
August, 2021 - present